0
Non-Opioid Directive Act
12/31/2022, 4:59 AM
Summary of Bill HR 4098
The Non-Opioid Directive Act would require healthcare providers to offer non-opioid pain management options to patients before prescribing opioids. This includes non-addictive medications, physical therapy, and other non-pharmacological treatments. The bill also aims to increase education and awareness about the risks of opioid use and the availability of non-opioid alternatives.
Additionally, the Non-Opioid Directive Act would establish a grant program to support research and development of non-opioid pain management treatments. This funding would be used to incentivize the development of new, innovative approaches to pain management that do not rely on opioids. Overall, the goal of Bill 117 HR 4098 is to reduce the overreliance on opioids for pain management and to help combat the opioid epidemic in the United States. By promoting non-opioid alternatives and increasing access to these treatments, the bill aims to improve patient outcomes and reduce the number of opioid-related deaths and addictions.
Congressional Summary of HR 4098
Non-Opioid Directive Act
This bill requires the Department of Health and Human Services (HHS) to develop a non-opioid pain management directive. This is a form that an individual may use to inform health care providers of the individual's choice to avoid opioid medications for pain management. The bill also sets out requirements for the execution, use, and revocation of these forms.
HHS must make the form available on its website, and health insurers must make it available to their plan enrollees. Insurers must also share an enrollee's choice about opioid treatment with health care providers during pre-authorization processes.
The bill allows health care providers to override a patient's form in specified circumstances. It also extends liability protections for providers who reasonably and in good faith administer or prescribe an opioid to a patient with an executed form in place.
